CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 23 No. 13
INTEGRATIVE ONCOLOGY 

Oxygen Therapies

Complementary Therapies, Herbs, and Other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | December 1, 2009
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Oxygen therapies are expensive, unproven, and harmful alternatives promoted in appealing and convincing ways for the treatment of cancer and other major diseases. Supporters claim that low levels of oxygen enable cancer cells to thrive and that an oxygen-rich environment destroys them. However, these claims are unsubstantiated. Further, numerous reports of serious complications and fatalities have been reported from the use of oxygen therapies.

The American Cancer Society strongly urges cancer patients not to seek oxygen treatments. Patients should be advised to avoid questionable, alternative treatments and informed of the dangers associated with these therapies.

—Barrie Cassileth, PhD

ALSO KNOWN AS: Oxymedicine, bio-oxidative therapy, oxidative therapy, oxidology, hydrogen peroxide(Drug information on hydrogen peroxide) therapy, ozone therapy, ozonolysis, hyperoxygenation therapies, hyperoxygenated water.

SUMMARY: Oxygen therapies are unproven alternatives promoted as a cure for cancer, acquired immune deficiency syndrome (AIDS), and other degenerative diseases. These “therapies” are offered at clinics in Mexico, the United States, and Europe. Proponents claim that many diseases, including cancer, are caused by oxygen deficiency and that oxygenation can restore health by destroying cancer cells, eliminating pathogens, stimulating metabolism, and by producing “oxidative detoxification.” There is no scientific evidence to support any of these claims.

Oxygen therapies include: (1) hydrogen peroxide therapy involving intravenous infusion, ingestion, colonic administration, or soaking in hydrogen peroxide solution; (2) ozone colonics and ozone autohemotherapy, in which blood is withdrawn and treated with ozone before reinfusion, and (3) “oxygenated” water, pills, and solutions.

The use of oxygen therapies has resulted in serious adverse events and several deaths.

Oxygen therapies should not be confused with those commonly used in respiratory care.

ADVERSE EFFECTS: Common (intrarectal hydrogen peroxide): Numerous cases of hydrogen peroxide-induced ulcerative colitis and sepsis have been reported.[1]

Case Report (intravenous hydrogen peroxide): In a 51-year-old AIDS patient, injection of 35% hydrogen peroxide into the subclavian vein catheter caused Heinz body hemolytic anemia, subsequent hemoglobinuria, and death from progressive renal insufficiency with multiple electrolyte abnormalities.[2] Case Report (oral hydrogen peroxide): Ingestion of 30% to 40% hydrogen peroxide solution resulted in three deaths from gas embolism and circulatory collapse.[3]

In addition, two cases of cerebral embolism were reported after ingestion of 30% to 40% hydrogen peroxide solution.[4,5] Common (subcutaneous ozone): Local pain, burning, erythema, edema, and hematoma.[6]

Transmission of blood-borne viruses such as hepatitis C and HIV was reported after treatment with contaminated autohemotherapy devices.[7]

DRUG INTERACTIONS: Oxygen may potentiate the pulmonary toxicity of bleomycin(Drug information on bleomycin).[8]

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Andrew Nash | March 30, 2010 9:01 AM EDT

Binh: The complete item has been posted. This is just a one-page overview. For more information, we encourage you to visit Memorial Sloan-Kettering's Integrative Medicine site here: http://www.mskcc.org/mskcc/html/69317.cfm





REFERENCES: 1. Shaw A, Cooperman A, Fusco J: Gas embolism produced by hydrogen peroxide. N Engl J Med 277:238-241, 1967.
2. Hirschtick RE, Dyrda SE, Peterson LC: Death from an unconventional therapy for AIDS. Ann Intern Med 120:694, 1994.
3. Meyer CT, Brand M, DeLuca VA, et al: Hydrogen peroxide colitis: A report of three patients. J Clin Gastroenterol 3:31-35, 1981.
4. Giberson TP, Kern JD, Pettigrew DW 3rd, et al: Near-fatal hydrogen peroxide ingestion. Ann Emerg Med 18:778-779, 1989.
5. Sherman SJ, Boyer LV, Sibley WA: Cerebral infarction immediately after ingestion of hydrogen peroxide solution. Stroke 25:1065-1067, 1994.
6. Franzini M, et al: Subcutaneous oxygen-ozone therapy in indurative hypodermatitis and in localized lipodystrophies: A clinical study of efficacy and tolerability. Acta Toxicol Ther 14:273-288, 1993.
7. Daschner FD: Hepatitis C and human immunodeficiency virus infection following ozone autohemotherapy. Eur J Clin Microbiol Infect Dis 16:620, 1997.
8. Ingrassia TS 3rd, Ryu JH, Trastek VF, et al: Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc 66:173-178, 1991.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy